Effect of disease‐modifying agents and their association with mortality in multi‐morbid patients with heart failure with reduced ejection fraction
Abstract Aims An increasing proportion of patients with heart failure with reduced ejection fraction (HFrEF) have co‐morbidities. The effect of these co‐morbidities on modes of death and the effect of disease‐modifying agents in multi‐morbid patients is unknown. Methods and results We performed a pr...
Gardado en:
| Principais autores: | , , , , , , , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Oxford University Press
2020-12-01
|
| Series: | ESC Heart Failure |
| Assuntos: | |
| Acceso en liña: | https://doi.org/10.1002/ehf2.12978 |
| Tags: |
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|
